glp-1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:
Description
Looking for alternatives to medication that will get more of this hormone in your body
![glp-1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41569-023-00849-3/MediaObjects/41569_2023_849_Fig5_HTML.png)
Phase 3 data report ~16.6% mean weight loss with adherence, with outcomes comparable to injectable Wegovy 2.4 mg
![glp-1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/11466209/7560e04abce0/JOE-24-0046fig1.jpg)
In an update posted on its website on 2 January 2024, the US FDA confirmed that it was carrying out the []
![glp-1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://www.mdpi.com/ijms/ijms-25-04407/article_deploy/html/images/ijms-25-04407-g003.png)
A licensed physician will determine if treatment is appropriate for you
![glp-1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://www.researchgate.net/publication/221821971/figure/fig4/AS:305413300998144@1449827613172/ndirect-cardiac-actions-of-GLP-1-In-addition-to-direct-actions-on-the-cardiomyocyte.png)
Result: GLP-1s lowered osteoporosis risk (31% reduction)
![glp-1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](http://www.jacc.org/cms/asset/19e854b9-04a9-4150-9edd-0142adf0c8a6/ga1.jpg)